Vertex Pharmaceuticals Incorporated current ratio

The Current Ratio as of November 2026 (TTM) for Vertex Pharmaceuticals Incorporated (VRTX) is 2.34

According to Vertex Pharmaceuticals Incorporated’s latest financial reports and current stock price. The company's current Current Ratio is 2.34. This represents a change of -18.33% compared to the average of 2.86 of the last 4 quarters.

Vertex Pharmaceuticals Incorporated (VRTX) Historical Current Ratio (quarterly & annually)

How has VRTX Current Ratio performed in the past?

The mean historical Current Ratio of Vertex Pharmaceuticals Incorporated over the last ten years is 3.58. The current 2.34 Current Ratio has changed -34.79% with respect to the historical average. Over the past ten years (40 quarters), VRTX's Current Ratio was at its highest in in the December 2022 quarter at 4.83. The Current Ratio was at its lowest in in the December 2016 quarter at 2.31.

Vertex Pharmaceuticals Incorporated (VRTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vertex Pharmaceuticals Incorporated Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vertex Pharmaceuticals Incorporated (VRTX) Average Current Ratio

How has VRTX Current Ratio performed in the past?

The current Current Ratio of Vertex Pharmaceuticals Incorporated (VRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vertex Pharmaceuticals Incorporated (VRTX) Current Ratio vs. Peers

How is VRTX’s Current Ratio compared to its peers?

Vertex Pharmaceuticals Incorporated’s Current Ratio is less than BioMarin Pharmaceutical Inc. (2.44), greater than Ultragenyx Pharmaceutical Inc. (1.40), less than Ionis Pharmaceuticals, Inc. (7.88), less than PTC Therapeutics, Inc. (3.27), less than Sarepta Therapeutics, Inc. (4.42), greater than BridgeBio Pharma, Inc. (2.09), less than Alnylam Pharmaceuticals, Inc. (2.48), less than Beam Therapeutics Inc. (13.00), less than CRISPR Therapeutics AG (16.21), less than Intellia Therapeutics, Inc. (6.65),

Build a custom stock screener for Vertex Pharmaceuticals Incorporated (VRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vertex Pharmaceuticals Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vertex Pharmaceuticals Incorporated (VRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vertex Pharmaceuticals Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.